Logo image of DYA.CA

DYNACERT INC (DYA.CA) Stock Fundamental Analysis

TSX:DYA - Toronto Stock Exchange - CA26780A1084 - Common Stock - Currency: CAD

0.15  +0.01 (+7.14%)

Fundamental Rating

2

Overall DYA gets a fundamental rating of 2 out of 10. We evaluated DYA against 14 industry peers in the Electrical Equipment industry. DYA has a bad profitability rating. Also its financial health evaluation is rather negative. DYA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year DYA has reported negative net income.
DYA had a negative operating cash flow in the past year.
DYA had negative earnings in each of the past 5 years.
DYA had a negative operating cash flow in each of the past 5 years.
DYA.CA Yearly Net Income VS EBIT VS OCF VS FCFDYA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

The Return On Assets of DYA (-174.27%) is worse than 71.43% of its industry peers.
Looking at the Return On Equity, with a value of -3504.26%, DYA is doing worse than 78.57% of the companies in the same industry.
Industry RankSector Rank
ROA -174.27%
ROE -3504.26%
ROIC N/A
ROA(3y)-201.12%
ROA(5y)-150.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DYA.CA Yearly ROA, ROE, ROICDYA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DYA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DYA.CA Yearly Profit, Operating, Gross MarginsDYA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

More info and screens

0

2. Health

2.1 Basic Checks

DYA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DYA has more shares outstanding
DYA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DYA is higher compared to a year ago.
DYA.CA Yearly Shares OutstandingDYA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
DYA.CA Yearly Total Debt VS Total AssetsDYA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

DYA has an Altman-Z score of -20.54. This is a bad value and indicates that DYA is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -20.54, DYA is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
DYA has a Debt/Equity ratio of 6.49. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 6.49, DYA is doing worse than 78.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 6.49
Debt/FCF N/A
Altman-Z -20.54
ROIC/WACCN/A
WACC8.82%
DYA.CA Yearly LT Debt VS Equity VS FCFDYA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 0.75 indicates that DYA may have some problems paying its short term obligations.
DYA's Current ratio of 0.75 is on the low side compared to the rest of the industry. DYA is outperformed by 85.71% of its industry peers.
DYA has a Quick Ratio of 0.75. This is a bad value and indicates that DYA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.63, DYA is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.63
DYA.CA Yearly Current Assets VS Current LiabilitesDYA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

6

3. Growth

3.1 Past

DYA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.30%.
The Revenue has grown by 412.15% in the past year. This is a very strong growth!
Measured over the past years, DYA shows a quite strong growth in Revenue. The Revenue has been growing by 8.61% on average per year.
EPS 1Y (TTM)-21.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-83.33%
Revenue 1Y (TTM)412.15%
Revenue growth 3Y28.22%
Revenue growth 5Y8.61%
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, DYA will show a very strong growth in Earnings Per Share. The EPS will grow by 55.65% on average per year.
Based on estimates for the next years, DYA will show a very strong growth in Revenue. The Revenue will grow by 263.86% on average per year.
EPS Next Y100%
EPS Next 2Y55.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year656.55%
Revenue Next 2Y263.86%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DYA.CA Yearly Revenue VS EstimatesDYA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
DYA.CA Yearly EPS VS EstimatesDYA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2026 0 -0.02 -0.04

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DYA. In the last year negative earnings were reported.
DYA is valuated correctly with a Price/Forward Earnings ratio of 14.85.
Based on the Price/Forward Earnings ratio, DYA is valued a bit cheaper than 71.43% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.13. DYA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 14.85
DYA.CA Price Earnings VS Forward Price EarningsDYA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DYA.CA Per share dataDYA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 -0.02

4.3 Compensation for Growth

DYA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DYA's earnings are expected to grow with 55.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.65%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DYA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DYNACERT INC

TSX:DYA (6/13/2025, 7:00:00 PM)

0.15

+0.01 (+7.14%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-14 2025-05-14
Earnings (Next)08-12 2025-08-12
Inst Owners5.16%
Inst Owner ChangeN/A
Ins Owners8.23%
Ins Owner ChangeN/A
Market Cap71.31M
Analysts84
Price Target0.77 (413.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.85
P/S 37.5
P/FCF N/A
P/OCF N/A
P/B 218.53
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)0.01
Fwd EY6.73%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -174.27%
ROE -3504.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-201.12%
ROA(5y)-150.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 6.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.97%
Cap/Sales 0.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.63
Altman-Z -20.54
F-Score5
WACC8.82%
ROIC/WACCN/A
Cap/Depr(3y)6.19%
Cap/Depr(5y)101.41%
Cap/Sales(3y)7.56%
Cap/Sales(5y)101.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-83.33%
EPS Next Y100%
EPS Next 2Y55.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)412.15%
Revenue growth 3Y28.22%
Revenue growth 5Y8.61%
Sales Q2Q%N/A
Revenue Next Year656.55%
Revenue Next 2Y263.86%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-68.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.01%
OCF growth 3YN/A
OCF growth 5YN/A